ombitasvir/paritaprevir/ritonavir/dasabuvir

ombitasvir/paritaprevir/ritonavir/dasabuvir is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.

Pronunciation:
om-bit-as-vir/par-i-ta-pre-vir/ri-toe-na-vir/da-sa-bue-vir

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Holkira Pak Canadian Trade name
  • Viekira Pak

Ther. Class.

antivirals

Pharm. Class.

NS5 inhibitors

protease inhibitors

enzyme inhibitors

non-nucleoside NS5B palm

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.

Pronunciation:
om-bit-as-vir/par-i-ta-pre-vir/ri-toe-na-vir/da-sa-bue-vir

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Holkira Pak Canadian Trade name
  • Viekira Pak

Ther. Class.

antivirals

Pharm. Class.

NS5 inhibitors

protease inhibitors

enzyme inhibitors

non-nucleoside NS5B palm

There's more to see -- the rest of this topic is available only to subscribers.